• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN SURGICAL SA NOVOSYN VIOLET 1 (4) 90CM HS37S (M); SUTURES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN SURGICAL SA NOVOSYN VIOLET 1 (4) 90CM HS37S (M); SUTURES Back to Search Results
Model Number C0068583
Device Problem Device Issue (2379)
Patient Problem Seroma (2069)
Event Date 01/30/2018
Event Type  malfunction  
Manufacturer Narrative
Samples received: two unopened pouches (to analyze (b)(4)).Analysis and results: there are no previous complaints of this code batch.We have received the same day 6 cases of seroma after surgery from the same hospital and three possible codes-batches involved.We manufactured and distributed in the market (b)(4) units of this code batch.There are no units in our stock.We have received two closed samples to analyze (b)(4).We have checked these samples and no defects have been found.Tightness test to the samples received has been performed and the units are tight.We have tested the knot pull tensile strength of the samples received and the results fulfil the requirements of the (b)(4): 6.45 kgf in average and 6.36 kgf in minimum (ep requirements: 5.18 kgf in average and 2.59 kgf in minimum).Furthermore, degradation test results conducted on the samples received fulfil b.Braun surgical requirements.In the degradation test, threads are introduced in a 0.9 % nacl solution at 37ºc for 14 days.After this period, the knot pull tensile strength of the thread is tested.The results for the samples received are 4.65 kgf in average and 4.46 kgf in minimum.B.Braun surgical requirement is 2.69 kgf in minimum.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfill usp/ep and b.Braun surgical requirements.Sterilization process was also normal and the results of the sterilization control are correct.Novosyn biocompatibility has been tested in several experiments.In sensitization and irritation tests the harmlessness of novosyn was proved.Final conclusion: although the results of the samples received fulfil the specifications of (b)(4) / b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Event Description
Country of complaint: (b)(6).Seroma 2-3 days after surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOSYN VIOLET 1 (4) 90CM HS37S (M)
Type of Device
SUTURES
Manufacturer (Section D)
B.BRAUN SURGICAL SA
121 carretera de terrassa
rubi, barcelona 08191
SP  08191
Manufacturer (Section G)
B.BRAUN SURGICAL SA
121 carretera de terrassa
rubi, barcelona 08191
SP   08191
Manufacturer Contact
nicole broyles
615 lambert pointe drive
hazelwood, MO 63042
3145515988
MDR Report Key7311086
MDR Text Key101714659
Report Number3003639970-2018-00111
Device Sequence Number1
Product Code GAM
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K122734
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 03/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/16/2022
Device Model NumberC0068583
Device Catalogue NumberC0068583
Device Lot Number117114
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/06/2018
Distributor Facility Aware Date02/05/2018
Date Manufacturer Received02/05/2018
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-